(1E,4E)-1,5-Bis(4-fluorophenyl)penta-1,4-dien-3-one

Catalog No.: 
ACGUIY382
CAS No.: 
53369-00-9
Molecular Formula: 
C17H12F2O
Molecular Weight: 
270.28
(1E,4E)-1,5-Bis(4-fluorophenyl)penta-1,4-dien-3-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$147.00In stockInquiry
100g98%$576.00In stockInquiry
500g98%$2258.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1E,4E)-1,5-Bis(4-fluorophenyl)penta-1,4-dien-3-one
IUPAC Name(1E,4E)-1,5-bis(4-fluorophenyl)penta-1,4-dien-3-one
MDL No.MFCD00298485
Molecular FormulaC17H12F2O
Molecular Weight270.28
SMILESO=C(/C=C/C1=CC=C(F)C=C1)/C=C/C2=CC=C(F)C=C2
InChI KeyBNHFGYIPXPENKA-YDWXAUTNSA-N
Synonymtrans,trans-Bis(4-fluorobenzal)acetone | trans,trans-Bis(4-fluorobenzylidene)acetone | trans,trans-Bis(4-fluorostyryl) Ketone
CAS No.53369-00-9
PubChem CID1268251

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACGUIY382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGUIY382 route product structure diagram
    ACGUIY38253369-00-9In Stock
Inquiry

2. ACGUIY382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGUIY382 route product structure diagram
    ACGUIY38253369-00-9In Stock
Inquiry

3. ACGUIY382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGUIY382 route product structure diagram
    ACGUIY38253369-00-9In Stock
Inquiry

Comments (0)